Search Tag: Siemens
2021 08 Oct
Executive Summary Cancer care is becoming increasingly complex and personalized. More and more patient characteristics and disease specific data – clinical history, comorbidities, imaging, laboratory data, genomics/ proteomics, lifestyle factors, pathology results – have to be factored in when deciding on diagnostic measures and care pathways....Read more
2021 27 Sep
The Supervisory Board of Siemens Healthineers AG has appointed Dr. Marion Helmes as Chairwoman of the Audit Committee today. On September 28, 2021, she will take over the Chair from Dr. Andreas C. Hoffmann who has held this position since 2020. Marion Helmes has been an independent member of the Supervisory Board and its Audit Committee since the...Read more
2020 12 Feb
At this year’s Annual Shareholders’ Meeting of Siemens Healthineers AG, one major focus is the MedTech company’s mid-term development. “In the past fiscal year, the Managing Board has further developed the business in a significant way and, in doing so, set the right course,” Prof. Dr. Ralf P. Thomas, the new Chairman of the Supervisory Board, told...Read more
2017 16 Feb
Healthcare organizations do a phenomenal job. Today, an increasing number of diseases are treated successfully and people enjoy a better quality of life even into old age. Yet, while much is being done to discover new ways to improve patients' lives, we now see radical changes to structures, incentives, and processes within healthcare to sustain provision...Read more
2015 29 Jan
Siemens has just named Bernd Montag as the new CEO of its health care business. Montag will replace Hermann Requardt as of February 1. In other changes announced by the company, Janina Kugel will join the Managing Board and Michael Reitermann will be appointed as a member of the Executive Management. Michael Sen will step in as the Chief Financial...Read more
2013 17 Dec
Siemens Healthcare Diagnostics Inc. announced that it has entered into a master collaboration agreement with Pfizer Inc. to design, develop and commercialise diagnostic tests for therapeutic products across Pfizer’s pipeline. Under the agreement, Siemens will be one of Pfizer’s collaboration partners to develop and provide in vitro diagnostic tests...Read more